Clinical Trial Update: Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial aims to determine if blood eosinophil counts can guide the use of systemic corticosteroids during asthma exacerbations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Asthma Exacerbation

Snippet

Sponsor: Changi General Hospital | Conditions: Asthma Attack, Asthma | Phase 2 | Status: ACTIVE_NOT_RECRUITING